HCA Healthcare is one of the largest for-profit operators of healthcare facilities in the United States. The company runs a network of hospitals, surgery centers, and emergency rooms. Its revenue depends on its "payer mix," which is the blend of payments from private insurance, government programs, and uninsured patients, a critical factor in the healthcare industry.
Reflecting a more cautious view, Wells Fargo analyst Stephen Baxter lowers the price target for HCA Healthcare to $369.00 from a previous target of $428.00. A price target is an analyst's estimate of a stock's future value. This new target was set while HCA Healthcare was trading at $371.18, suggesting the analyst expects limited price growth in the healthcare stock.
This adjustment follows HCA Healthcare's decision to lower its own financial forecasts for 2026. The company now projects its earnings per share (EPS) to be between $28.70 and $30.50. This is down from the earlier forecast of $29.10 to $31.50. EPS shows how much profit the company makes for each share of its stock, impacting investor sentiment and profitability metrics.
The company also narrows its 2026 sales guidance to a range of $77.00 billion to $79.50 billion. As highlighted by The Wall Street Journal, HCA Healthcare attributes this change to shifts in its payer mix. An increase in uninsured patients during the second quarter is a key factor, as highlighted by Barrons, reflecting broader healthcare market trends and challenges with uninsured patients.
Despite the lowered outlook, HCA Healthcare reports strong preliminary second-quarter results. Revenue is approximately $20.23 billion, an increase from $18.61 billion a year ago. Operationally, same-facility admissions and emergency room visits also show an increase, indicating continued demand for its healthcare services and strong operational performance.
